Literature DB >> 11049762

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.

T Yeghen1, C C Kibbler, H G Prentice, L A Berger, R K Wallesby, P H McWhinney, F C Lampe, S Gillespie.   

Abstract

Eighty-seven patients with hematologic malignancies and invasive pulmonary aspergillosis (IPA) were identified between 1982 and 1995. Of these, 39 underwent lung resection on the basis of radiological detection of at least 1 lesion with imaging suggestive of aspergillosis (LISA). IPA was confirmed histologically in 35. The presence of LISA had 90% positive predictive value for IPA. The actuarial survival at 2 years was 36% for 37 patients treated surgically, 20% for 12 patients with unresected LISA but no cultures of Aspergillus species, and 5% for 21 patients diagnosed only by isolation of Aspergillus from respiratory secretions. Analysis by proportional hazard models showed a significant independent negative association between the radiological appearance of LISA and death from all causes. Relapsed hematologic disease was independently significantly associated with death. Age, sex, surgery, previous bone marrow transplantation, or Aspergillus isolation were not independent predictors of death. IPA presenting as LISA carries a relatively good prognosis, possibly explaining the better survival of patients undergoing surgery for such lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049762     DOI: 10.1086/318133

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

Review 1.  [The radiology of opportunistic pneumonias. I: Epidemiological, laboratory and clinical background].

Authors:  S Tuengerthal
Journal:  Radiologe       Date:  2005-04       Impact factor: 0.635

2.  Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Authors:  Simone Aranha Nouér; Marcio Nucci; Naveen Sanath Kumar; Monica Grazziutti; Alejandro Restrepo; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

3.  Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.

Authors:  Christiaan A Rees; Pierre-Hugues Stefanuto; Sarah R Beattie; Katherine M Bultman; Robert A Cramer; Jane E Hill
Journal:  J Breath Res       Date:  2017-08-21       Impact factor: 3.262

4.  Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.

Authors:  M Michallet; T Bénet; M Sobh; S Kraghel; M El Hamri; G Cannas; F E Nicolini; H Labussière; S Ducastelle; F Barraco; X Thomas; Y Chelghoum; M-C Nicolle; A-L Bienvenu; F Persat; F De Monbrison; S Picot; P Vanhems
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-10       Impact factor: 3.267

Review 5.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

6.  Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.

Authors:  H-C Hsiue; T-H Wu; T-C Chang; Y-C Hsiue; Y-T Huang; P-I Lee; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

7.  Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection.

Authors:  Ikuko Nakamura; Ryuichi Kanasaki; Koji Yoshikawa; Shigetada Furukawa; Akihiko Fujie; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2016-08-31       Impact factor: 2.649

8.  Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.

Authors:  A Azzola; J R Passweg; J M Habicht; L Bubendorf; M Tamm; A Gratwohl; G Eich
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections.

Authors:  P J Paterson; S Seaton; J McLaughlin; C C Kibbler
Journal:  Mol Pathol       Date:  2003-12

10.  Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.

Authors:  Laura K Najvar; Anthony Cacciapuoti; Steve Hernandez; Judith Halpern; Rosie Bocanegra; Maya Gurnani; Frederick Menzel; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.